Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
5.69
-0.21 (-3.56%)
At close: May 27, 2025, 4:00 PM
6.09
+0.40 (7.03%)
After-hours: May 27, 2025, 6:32 PM EDT
Coya Therapeutics Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Coya Therapeutics stock ranges from a low of $14 to a high of $18. The average analyst price target of $17 forecasts a 198.77% increase in the stock price over the next year.
Price Target: $17.00 (+198.77%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Coya Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Chardan Capital | Chardan Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +146.05% | May 13, 2025 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +146.05% | Apr 28, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $18 | Strong Buy | Maintains | $18 | +216.34% | Apr 24, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $18 | Strong Buy | Maintains | $18 | +216.34% | Apr 22, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $18 | Strong Buy | Maintains | $18 | +216.34% | Mar 27, 2025 |
Financial Forecast
Revenue This Year
6.91M
from 3.55M
Increased by 94.45%
Revenue Next Year
n/a
from 6.91M
EPS This Year
-1.03
from -0.98
EPS Next Year
-1.81
from -1.03
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 9.6M | n/a | 15.8M | ||
Avg | 6.9M | n/a | 12.8M | ||
Low | 2.1M | n/a | 9.8M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 168.8% | - | - | ||
Avg | 94.5% | - | - | ||
Low | -42.1% | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.78 | -1.51 | -0.68 | ||
Avg | -1.03 | -1.81 | -0.85 | ||
Low | -1.31 | -2.26 | -1.00 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.